Humana (HUM) Other Operating Expenses (2009 - 2026)

Humana (HUM) has reported Other Operating Expenses for 18 consecutive years, with $35.3 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Other Operating Expenses rose 28.32% year-over-year to $35.3 billion in Q2 2026; TTM through Jun 2026 was $69.0 billion, a 27.57% increase from a year earlier, with the FY2025 full-year figure at -$67.0 million, changed N/A from the prior year.
• Other Operating Expenses was $35.3 billion for Q2 2026 at Humana, up from $33.7 billion in the prior quarter.
• Over five years, Other Operating Expenses peaked at $35.3 billion in Q2 2026 and troughed at -$63.0 million in Q3 2025.
• A 5-year average of $18.3 billion and a median of $21.9 billion in 2023 frame the typical range for Other Operating Expenses.
• Across the five-year window, Other Operating Expenses increased 5.62% in 2025 and advanced 28.32% in 2026, its largest moves.
• Over 5 years, Other Operating Expenses stood at -$3.0 million in 2022, then surged by 733100.0% to $22.0 billion in 2023, then advanced by 13.79% to $25.0 billion in 2024, then slumped by 100.02% to -$4.0 million in 2025, then surged by 883825.0% to $35.3 billion in 2026.
• The last three Other Operating Expenses figures came in at $35.3 billion (Q2 2026), $33.7 billion (Q1 2026), and -$4.0 million (Q4 2025), per Business Quant data.